We value ACL at 14x CY23E EV/EBITDA (including Ambuja stake in ACC with no holding company discount) to arrive at TP of Rs 365/share, implying a downside of 2% from the CMP as we attach a lower value to Ambuja's stake in ACC Limited and hence change our rating on the stock from BUY to HOLD.